-
公开(公告)号：US20240409656A1
公开(公告)日：2024-12-12
申请号：US18664772
申请日：2024-05-15
Applicant: GENMAB A/S
Inventor： Nurgul KILAVUZ , Mariana SACCHI
Abstract: The present invention relates to improved methods for reducing cytokine release syndrome following interruption of the epcoritamab dosing schedule for the treatment of CD20 B-cell expressing cancers.
Search Results
1
records
(took 0.016 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
